Neutrogena Makeup Wipes Recalled Due to Potential Bacterial Contamination

Federal safety regulators announced the voluntary recall of over 15,000 packages of Neutrogena makeup wipes due to concerns of potential bacterial contamination. The recalled wipes were distributed in Florida, Georgia, South Carolina, and Texas, and may have been contaminated with Pluralibacter gergoviae, a bacterium that can cause infections, particularly in individuals with weakened immune systems or chronic illnesses.

Key Takeaways:

  • The recall affects 15,000 packages of Neutrogena makeup wipes due to potential bacterial contamination with Pluralibacter gergoviae.
  • The contaminated wipes were distributed in Florida, Georgia, South Carolina, and Texas.
  • Kenvue, Neutrogena's parent company, issued the recall out of an abundance of caution, citing no other Neutrogena products were exposed to the bacteria.
  • Pluralibacter gergoviae can cause serious infections in immunocompromised individuals, including eye infections, urinary tract infections, sepsis, and respiratory diseases.
  • Preservatives commonly found in cosmetic and personal health products do not kill the bacteria, according to Melbec Microbiology.
  • Other personal care companies, such as Amika and Kao USA (Jergens), have also issued recalls due to Pluralibacter gergoviae contamination.
  • The recall was upgraded to a Class II by the FDA, indicating use or exposure could cause temporary or medically reversible adverse health consequences.

Statistics:

  • 15,000: Number of packages of Neutrogena makeup wipes recalled due to potential bacterial contamination.
  • 1,312 cases: Number of cases affected by the recall.
  • 12 packages per case: Total number of packages in each case.
  • 1835U6325A: Lot number of the recalled wipes.
  • September 19: Date the original recall went into effect.
  • October 3: Date the recall was upgraded to a Class II.

Sources:

  • Food and Drug Administration (FDA)
  • Kenvue (Neutrogena's parent company)
  • Melbec Microbiology
  • The New York Times
  • The Wall Street Journal